Greenland Mines files rights agreement with rights agent
Greenland Mines Ltd. has executed a Rights Agreement with Continental Stock Transfer & Trust Co., dated as of July 22, 2026. Legal counsel highlighted as Exhibit 4.1 in an SEC 8-K …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Greenland Mines Ltd. has executed a Rights Agreement with Continental Stock Transfer & Trust Co., dated as of July 22, 2026. Legal counsel highlighted as Exhibit 4.1 in an SEC 8-K …
Inhibikase Therapeutics announced the FDA granted Orphan Drug Designation for its pulmonary arterial hypertension treatment, IKT-001. This benefit includes potential tax credits an…
Incannex has started screening participants for its IHL-42X Phase 2 OSA trial. The company previously received FDA Fast Track designation for the drug.
Investment firm Bleichroeder Acquisition Corp. II amended its Business Combination Agreement with Pasqal to modify the terms of an equity incentive plan prior to the deal's closing…
Kala Bio, Inc. announced that the SEC has declared effective the proxy statement related to its upcoming annual meeting. This regulatory clearance is required to proceed with share…
The FDA selected the first manufacturer for its Technology-Enabled Meaningful Patient Outcomes Pilot focused on digital health devices.
Bluejay Diagnostics completed enrollment in its SYMON-II study testing Symphony IL-6 for sepsis mortality risk ahead of plan, potentially supporting future regulatory filings and c…
The company filed an exhibit for an amended and restated revolving credit facility indenture and security agreement. The market relevance is neutral as it confirms existing planned…
Getty Realty filed an 8-K updating its corporate profile to incorporate information regarding the use of non-GAAP financial measures like FFO and AFFO.
Macau's Land and Urban Construction Bureau approved Wynn Resorts' application to expand Wynn Palace with a new hotel tower and event center. The approval omits casino floor alterat…
BridgeBio Pharma announced FDA acceptance of a new drug application for encaleret targeting autosomal dominant hypocalcemia type 1, setting a target action date of May 8, 2027, and…
Consolidated Water received a Limited Notice to Proceed from the Honolulu Board of Water Supply, authorizing approximately $6 million for the procurement of long-lead equipment for…
The FDA announced steps to remove outdated authorizations for petroleum-based color additives, continuing efforts to improve food safety.
The John Deere Receivables 2026-B Ownership Trust filed exhibits related to debt legality and tax advice with the SEC, outlining legal counsel for the transaction structure.
WFRBS Commercial Mortgage Trust 2014-C20 filed an 8-K on July 17, 2026, as reported by the SEC. Market relevance is currently limited as this represents a standard regulatory filin…
Standards Nuclear announced construction is substantially complete and preliminary safety analyses were approved for two new fuel production facilities, advancing the company's TRI…
Evolution Metals received the first non-China NdPr metal shipment to support production of defense-compliant rare earth magnets, aligning with the July 2026 White House Executive O…
LB Pharmaceuticals moved up its Phase 3 schizophrenia trial topline results to the first half of 2027 due to rapid enrollment, while maintaining strong capitalization through late …
Monopar Therapeutics initiated a rolling New Drug Application submission for ALXN1840 to treat Wilson disease. This regulatory advance represents a potential first novel mechanism …
Updated analysis of the global Phase III HARMONi trial demonstrates statistically significant and consistent overall survival benefits for ivonescimab plus chemotherapy in both Wes…